| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | FLUORESCEIN LISICOL Basic information |
| Product Name: | FLUORESCEIN LISICOL | | Synonyms: | FLUORESCEIN LISICOL;Cholyl-L-Lysyl-Fluorescein (CLF);NRL 972;NRL972;NRL-972;L-Lysine, N6-[[(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)amino]thioxomethyl]-N2-[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]- | | CAS: | 140616-46-2 | | MF: | C51H63N3O11S | | MW: | 926.135 | | EINECS: | | | Product Categories: | | | Mol File: | 140616-46-2.mol |  |
| | FLUORESCEIN LISICOL Chemical Properties |
| density | 1.43±0.1 g/cm3(Predicted) | | form | solid | | pka | 3.63±0.10(Predicted) | | color | Red |
| | FLUORESCEIN LISICOL Usage And Synthesis |
| Uses | Fluorescein lisicol is a fluorescent-labelled bile salt and a marker of hepatic biliary transporter function. Fluorescein lisicol can be used for metabolic research[1]. | | References | [1] de Mey C, et al. Effects of renal insufficiency on the elimination of fluorescein lisicol (NRL972), an investigational marker of hepatic transporter function. Int J Clin Pharmacol Ther. 2015 Jul;53(7):523-30. DOI:10.5414/CP202280 |
| | FLUORESCEIN LISICOL Preparation Products And Raw materials |
|